Aliskiren CAS 173334-57-1

Pwodwi deskripsyon:

Non pwodwi: Aliskiren CAS non: 173334-57-1

 

Synonyms:            

(AS, S, dS, zS)-d-amine-N-(3-sid amine-2, 2-dimethyl-3-oxopropyl)--hydroxy-4-methoxy-3-(3-methoxypropoxy)-a, z-bis (1-methylethyl) benzeneoctanamide;

Rasilez;

(2S, 4S, 5S, 7S)-5-Amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy) benzyl]-8-methylnonanamide;

 

Chimik &PhysicalProperties:

Aparans: poud oswa likid

Asdi: ≥99,0%

Dansite: 1,067 g/cm3

Boiling Point: 748.4 ° c nan 760 mmHg

Flash Point: 406.4 ° c

Vape presyon: 1.12 E-24mmHg nan 25 ° c

Endeks nan Refraksyon: 1,514

 

Aliskiren (non komes Tekturna ak Rasilez) se premye nan yon klas Dwog ki rele inhibiteurs ren direk. Li itilize pou esansyel (prensipal) tansyon wo. Pandan ke yo te itilize pou tansyon wo, lot pi bon medikaman etidye yo tipikman rekomande akoz enkyetid nan pi wo Efe sou kote ak mwens prev benefis.

An desanm 2011, Novartis te kanpe yon jijman nan Dwog la apre dekouvri ogmante nonfatal kout, konplikasyon ren, potasyom san wo, ak tansyon ki ba nan moun ki gen dyabet ak pwoblem ren.

 

Si ou enterese nan pwodwi nou yo oswa gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

Pwodwi anba patant yo ofri pou R &D objektif selman. Sepandan, responsablite final la manti selman ak achte la.

Baj popilè: aliskiren cas 173334-57-1, manifaktire, founise, faktori, achte, an aksyon

• On: INS 365 CAS 211427-08-6
• Pwochen: CarbaMicacid, N - [(3aS, 4R, 6S, 6aR) -tetrahydro-6-hydroxy-2,2-diMethyl-4H-cyclopenta-1,3-dioxol-4-il] -, phenylMethyl Ester CAS 274693-53- 7